Kristoffel R. Dumon

Kristoffel R. Dumon

Auto-generated profile, based on publicly available information

Kristoffel R. Dumon

Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2023 in Journal of Surgical Education
Verified
Journal Article
Closed access
WYWilliam S. Yi
William S. Yi
ARArmaun D. Rouhi
Armaun D. Rouhi
CDCaoimhe C. Duffy
Caoimhe C. Duffy
YGYazid K. Ghanem
Yazid K. Ghanem
NWNoel N. Williams
Noel N. Williams
KDKristoffel R. Dumon
Kristoffel R. Dumon

24 June 2023 in Surgery
Verified
Journal Article
Closed access
ARArmaun D. Rouhi
Armaun D. Rouhi
JRJeffrey L. Roberson
Jeffrey L. Roberson
EKEmily Kindall
Emily Kindall
YGYazid K. Ghanem
Yazid K. Ghanem
ANAbdourahmane Ndong
Abdourahmane Ndong
KDKristoffel R. Dumon
Kristoffel R. Dumon

1 January 2010 in American Journal of Roentgenology
Verified
Journal Article
Closed access
DSDavid W. Swenson
David W. Swenson
MLMarc Levine
Marc Levine
SRStephen E. Rubesin
Stephen E. Rubesin
NWNoel N. Williams
Noel N. Williams
KDKristoffel Dumon
Kristoffel Dumon
OBJECTIVE. The purposes of this study were to assess the utility of barium studies after adjustments of laparoscopically inserted gastric bands and to identify a threshold stomal diameter for predicting which bands should be loosened because of excessive tightening.MATERIALS AND METHODS. A total of 246 patients with laparoscopically inserted adjustable gastric bands underwent 668 routine band adjustments and barium studies after each adjustment. Forty-one barium studies of 30 patients with tight bands necessitating readjustment were compared with barium studies of 41 patients acting as controls. Barium studies of nine patients with obstructive symptoms before adjustment were reviewed to correlate stomal diameter with symptoms. The data were analyzed for a threshold stomal diameter below which obstructive symptoms were likely to develop.RESULTS. Mean stomal diameters were 2.9 mm for the group with tight bands after routine adjustment, 9.5 mm for the control group, and 5.1 mm for the group with obstructive ...

5 December 2022 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
ARArmaun D. Rouhi
Armaun D. Rouhi
YGYazid K. Ghanem
Yazid K. Ghanem
GHGerard D. Hoeltzel
Gerard D. Hoeltzel
WYWilliam S. Yi
William S. Yi
JCJoy L. Collins
Joy L. Collins
KDKristoffel R. Dumon
Kristoffel R. Dumon

1 January 2003 in Pediatric Hematology and Oncology
Verified
Journal Article
Closed access
MSMartin Sebastian Staege
Martin Sebastian Staege
VGVictor Gorelov
Victor Gorelov
ABAndrej Bulankin
Andrej Bulankin
UFUte Fischer
Ute Fischer
KDKristoffel Dumon
Kristoffel Dumon
Stefan BurdachStefan Burdach
Stefan Burdach
In augmenting systemic anti-tumor immune response, the authors evaluated the genetic modification of Ewing family tumor (EFT) cell lines for use as allogeneic vaccines. EFT cell lines A673 and RD-ES were transfected with cDNAs for human interleukin (IL)-2 and/or HSV1 thymidine kinase (HSV1- tk ), respectively. Clones with high and stable secretion of IL-2 alone or with coexpression of functional HSV1- tk were obtained and their features were analyzed. IL-2 expressing clones derived from the A673 cell line demonstrated decreased expression of HLA class I molecules compared with the parental cell line and corresponding clones derived from RD-ES. However, IFN- n could upregulate the expression of HLA class I antigens by IL-2 transfected A673 cells. Ganciclovir induced apoptosis in double-transfected cell clones. IL-2/HSV1- tk cells continued to produce and release IL-2 after initial ganciclovir treatment. After n -irradiation, transfected clones released bioactive IL-2 in a quantity sufficient to activate T and natural killer cells in culture. A polyvalent allogeneic vaccine was also obtained using fusion of two different transgenic cell lines. The resulting hybrids inherited antigenic and transgenic characteristics of both parental cell lines. It is presumed that the cell lines generated here could be used as allogeneic vaccines for treatment of patients with EFTs.

21 October 2024 in Journal of Surgical Research
Verified
Journal Article
Closed access
ARArmaun D. Rouhi
Armaun D. Rouhi
SLSebastian Leon
Sebastian Leon
JRJeffrey L. Roberson
Jeffrey L. Roberson
LSLauren A. Shreve
Lauren A. Shreve
GNGregory J. Nadolski
Gregory J. Nadolski
KDKristoffel R. Dumon
Kristoffel R. Dumon